SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

20 May 2025 Evaluate
A decrease in the sales to Rs. 1085.15 millions was observed for the quarter ended March 2025. The sales stood at Rs. 1173.87 millions during the similar quarter previous year.Net Profit of the company move down -31.31% to Rs. 54.20  millions from Rs. 78.90 millions  in the same quarter last year.A decline of 167.91 millions was observed in the OP in the quarter ended March 2025 from 169.55 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1085.15 1173.87 -7.56 3756.36 3654.73 2.78 3756.36 3654.73 2.78
Other Income 15.54 15.31 1.50 56.21 46.91 19.83 56.21 46.91 19.83
PBIDT 167.91 169.55 -0.97 488.90 447.94 9.14 488.90 447.94 9.14
Interest 29.09 22.77 27.76 113.86 69.24 64.44 113.86 69.24 64.44
PBDT 138.82 146.78 -5.42 375.04 378.70 -0.97 375.04 378.70 -0.97
Depreciation 52.34 38.75 35.07 198.91 148.29 34.14 198.91 148.29 34.14
PBT 86.48 108.03 -19.95 176.13 230.41 -23.56 176.13 230.41 -23.56
TAX 32.28 29.13 10.81 58.68 62.84 -6.62 58.68 62.84 -6.62
Deferred Tax -1.14 42.01 -102.71 14.21 54.55 -73.95 14.21 54.55 -73.95
PAT 54.20 78.90 -31.31 117.45 167.57 -29.91 117.45 167.57 -29.91
Equity 487.26 487.26 0.00 487.26 487.26 0.00 487.26 487.26 0.00
PBIDTM(%) 15.47 14.44 7.13 13.02 12.26 6.19 13.02 12.26 6.19

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×